AAAAAA
Results:
1-20
|
Results: 20
Authors:
EIBL N
SCHNACK C
FRANK M
SCHERNTHANER G
Citation: N. Eibl et al., INITIAL URINARY ALBUMIN EXCRETION DETERMINES THE PROGRESSION OF MICROALBUMINURIA IN PATIENTS WITH TYPE-2 DIABETES AND NORMOTENSIVE BLOOD-PRESSURE VALUES DESPITE IMPROVED METABOLIC CONTROL, Diabetes research and clinical practice, 39(1), 1998, pp. 39-45
Authors:
EIBL N
SCHNACK C
SCHERNTHANER G
Citation: N. Eibl et al., MAGNESIUM SUPPLEMENTATION IN TYPE-2 DIABETES, Diabetes care, 21(11), 1998, pp. 2031-2032
Authors:
EIBL N
KRUGLUGER W
WAGNER S
SCHNACK C
HOPMEIER P
SCHERNTHANER G
Citation: N. Eibl et al., EFFECT OF A 1-YEAR TREATMENT WITH RAMIPRIL OR ATENOLOL ON ENDOTHELIALMARKERS IN PATIENTS WITH TYPE-2 DIABETES, Diabetologia, 41, 1998, pp. 1233-1233
Authors:
EQUILUZBRUCK S
SCHNACK C
KOPP HP
SCHERNTHANER G
Citation: S. Equiluzbruck et al., NONDIPPING OF NOCTURNAL BLOOD-PRESSURE IS RELATED TO URINARY ALBUMIN EXCRETION RATE IN PATIENTS WITH TYPE-2 DIABETES-MELLITUS, American journal of hypertension, 9(11), 1996, pp. 1139-1143
Authors:
SCHNACK C
FESTA A
SCHWARZMAIERDASSIE A
HABER P
SCHERNTHANER G
Citation: C. Schnack et al., PULMONARY DYSFUNCTION IN TYPE-1 DIABETES IN RELATION TO METABOLIC LONG-TERM CONTROL AND TO INCIPIENT DIABETIC NEPHROPATHY, Nephron, 74(2), 1996, pp. 395-400
Authors:
SCHNACK C
HOFFMANN W
HOPMEIER P
SCHERNTHANER G
Citation: C. Schnack et al., RENAL AND METABOLIC EFFECTS OF 1-YEAR TREATMENT WITH RAMIPRIL OR ATENOLOL IN NIDDM PATIENTS WITH MICROALBUMINURIA, Diabetologia, 39(12), 1996, pp. 1611-1616
Authors:
SCHNACK C
BIESENBACH G
KACEROVSKY G
MIHALJEVIC R
PECNIK I
PIEBER T
SCHERNTHANER G
Citation: C. Schnack et al., EVALUATION OF OPTIMAL THERAPY IN TYPE-2 DIABETIC-PATIENTS INSUFFICIENTLY TREATED WITH SULFONYLUREAS - THE AUSTRIAN INSULIN INTERVENTION STUDY, Diabetologia, 39, 1996, pp. 116-116
Authors:
EIBL N
SCHNACK C
FRANK M
SCHERNTHANER G
Citation: N. Eibl et al., PROGRESSION OF ADVANCED MICROALBUMINURIA IN NORMOTENSIVE TYPE-2 DIABETIC-PATIENTS DESPITE IMPROVED METABOLIC CONTROL, Diabetologia, 39, 1996, pp. 1172-1172
Authors:
GRIESMACHER A
KINDHAUSER M
ANDERT SE
SCHREINER W
TOMA C
KNOEBL P
PIETSCHMANN P
PRAGER R
SCHNACK C
SCHERNTHANER G
MUELLER MM
Citation: A. Griesmacher et al., ENHANCED SERUM LEVELS OF THIOBARBITURIC ACID-REACTIVE SUBSTANCES IN DIABETES-MELLITUS, The American journal of medicine, 98(5), 1995, pp. 469-475
Authors:
CAPEK M
SCHNACK C
LUDVIK B
KAUTZKYWILLER A
BANYAI M
PRAGER R
Citation: M. Capek et al., EFFECTS OF CAPTOPRIL TREATMENT VERSUS PLACEBO ON RENAL-FUNCTION IN TYPE-2 DIABETIC-PATIENTS WITH MICROALBUMINURIA - A LONG-TERM STUDY, The Clinical investigator, 72(12), 1994, pp. 961-966
Authors:
SCHNACK C
CAPEK M
BANYAI M
KAUTZKYWILLER A
PRAGER R
SCHERNTHANER G
Citation: C. Schnack et al., LONG-TERM TREATMENT WITH NIFEDIPINE REDUCES URINARY ALBUMIN EXCRETIONAND GLOMERULAR-FILTRATION RATE IN NORMOTENSIVE TYPE-1 DIABETIC-PATIENTS WITH MICROALBUMINURIA, Acta diabetologica, 31(1), 1994, pp. 14-18
Authors:
KNOBL P
SCHERNTHANER G
SCHNACK C
PIETSCHMANN P
PROIDL S
PRAGER R
VUKOVICH T
Citation: P. Knobl et al., HEMOSTATIC ABNORMALITIES PERSIST DESPITE GLYCEMIC IMPROVEMENT BY INSULIN THERAPY IN LEAN TYPE-2 DIABETIC-PATIENTS, Thrombosis and haemostasis, 71(6), 1994, pp. 692-697
Authors:
KNOBL P
PIETSCHMANN P
SCHNACK C
PRAGER R
SCHERNTHANER G
Citation: P. Knobl et al., APOLIPOPROTEIN(A) LEVELS IN PATIENTS WITH TYPE-1 DIABETES-MELLITUS ARE UNRELATED TO METABOLIC CONTROL OR VASCULAR-DISEASE, Wiener Klinische Wochenschrift, 106(23), 1994, pp. 728-732
Authors:
SCHNACK C
PIETSCHMANN P
KNOBL P
SCHULLER E
PRAGER R
SCHERNTHANER G
Citation: C. Schnack et al., APOLIPOPROTEIN (A) LEVELS AND ATHEROGENIC LIPID FRACTIONS IN RELATIONTO THE DEGREE OF URINARY ALBUMIN EXCRETION IN TYPE-2 DIABETES-MELLITUS, Nephron, 66(3), 1994, pp. 273-277
Authors:
EQUILUZBRUCK S
SCHNACK C
KOPP HP
SCHERNTHANER G
Citation: S. Equiluzbruck et al., NON-DIPPING OF NOCTURNAL BLOOD-PRESSURE IS RELATED TO URINARY ALBUMINEXCRETION RATE IN TYPE-2 DIABETES, Diabetologia, 37, 1994, pp. 10000143-10000143
Authors:
SCHERNTHANER G
SCHNACK C
HOPMEIER P
Citation: G. Schernthaner et al., EFFECT OF RAMIPRIL OR ATENOLOL ON MICROALBUMINURIA AND METABOLIC CONTROL PARAMETERS IN TYPE-2 DIABETES-MELLITUS, Diabetologia, 37, 1994, pp. 10000195-10000195
Authors:
FESTA A
SCHNACK C
DASSIE A
HABER P
SCHERNTHANER G
Citation: A. Festa et al., ABNORMAL PULMONARY-FUNCTION IN TYPE-1 DIABETES IS RELATED TO METABOLIC LONG-TERM CONTROL, BUT NOT TO URINARY ALBUMIN EXCRETION RATE, Diabetes, 43, 1994, pp. 10000196-10000196
Authors:
KNOBL P
SCHNACK C
PROIDL S
PRAGER R
VUKOVICH T
SCHERNTHANER G
Citation: P. Knobl et al., HEMOSTATIC ABNORMALITIES PERSIST DESPITE GLYCEMIC IMPROVEMENT BY INSULIN THERAPY IN TYPE-2 DIABETES-MELLITUS, Thrombosis and haemostasis, 69(6), 1993, pp. 806-806
Authors:
KNOBL P
SCHERNTHANER G
SCHNACK C
PIETSCHMANN P
GRIESMACHER A
PRAGER R
MULLER M
Citation: P. Knobl et al., THROMBOGENIC FACTORS ARE RELATED TO URINARY ALBUMIN EXCRETION RATE INTYPE-1 (INSULIN-DEPENDENT) AND TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS, Diabetologia, 36(10), 1993, pp. 1045-1050
Authors:
EIBL N
FESTA A
SCHNACK C
NOVAK H
HOPMEIER P
SCHERNTHANER G
Citation: N. Eibl et al., HYPOMAGNESEMIA IN TYPE-2 DIABETES-MELLITUS - EFFECT OF AN ORAL MAGNESIUM SUPPLEMENTATION, Diabetologia, 36, 1993, pp. 10000179-10000179
Risultati:
1-20
|